Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

This study has been withdrawn prior to enrollment.
(Lack of enrollment)
Sponsor:
Information provided by (Responsible Party):
Tarix Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01554254
First received: March 12, 2012
Last updated: August 29, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)